| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
|
Shiha, Gamal
|
|
2016
|
11 |
1 |
p. 1-30
|
article
|
| 2 |
Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics
|
Khan, Faisal Saeed
|
|
2016
|
11 |
1 |
p. 45-53
|
article
|
| 3 |
Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis
|
Haraguchi, Masafumi
|
|
2016
|
11 |
1 |
p. 125-131
|
article
|
| 4 |
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea
|
Jun, Chung Hwan
|
|
2016
|
11 |
1 |
p. 87-95
|
article
|
| 5 |
Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace
|
Lin, Chih-Lin
|
|
2017
|
11 |
1 |
p. 31-33
|
article
|
| 6 |
Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission
|
Gunardi, Hartono
|
|
2016
|
11 |
1 |
p. 96-104
|
article
|
| 7 |
Hepatocyte-like cells derived from induced pluripotent stem cells
|
Roy-Chowdhury, Namita
|
|
2016
|
11 |
1 |
p. 54-69
|
article
|
| 8 |
Interferon-free treatment for HCV-infected patients with decompensated cirrhosis
|
Kanda, Tatsuo
|
|
2016
|
11 |
1 |
p. 38-44
|
article
|
| 9 |
Live donor liver transplantation for alcoholic hepatitis
|
Singal, Ashwani K.
|
|
2016
|
11 |
1 |
p. 34-37
|
article
|
| 10 |
Molecular mechanisms of HBeAg in persistent HBV infection
|
Chen, Li-Min
|
|
2016
|
11 |
1 |
p. 79-86
|
article
|
| 11 |
Non-invasive diagnosis of hepatic steatosis
|
Stern, Christiane
|
|
2016
|
11 |
1 |
p. 70-78
|
article
|
| 12 |
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
|
Zweers, Serge J.
|
|
2016
|
11 |
1 |
p. 132-140
|
article
|
| 13 |
Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease
|
Wada, Nozomu
|
|
2016
|
11 |
1 |
p. 115-124
|
article
|
| 14 |
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
|
Kimura, Haruki
|
|
2016
|
11 |
1 |
p. 105-114
|
article
|
Journal description